this protocol describes an efficient method to site-specifically label cell-surface or purified proteins with chemical probes in two steps: probe incorporation mediated by enzymes (prIMe) followed by chelation-assisted copper-catalyzed azide-alkyne cycloaddition (cuaac). In the prIMe step, Escherichia coli lipoic acid ligase (lpla) site-specifically attaches a picolyl azide (paz) derivative to a 13-aa recognition sequence that has been genetically fused onto the protein of interest. proteins bearing paz are chemoselectively derivatized with an alkyne-probe conjugate by chelation-assisted cuaac in the second step. We describe herein the optimized protocols to synthesize paz to perform prIMe labeling and to achieve cuaac derivatization of paz on live cells, fixed cells and purified proteins. reagent preparations, including synthesis of paz probes and expression of lpla, take 12 d, whereas the procedure for performing site-specific paz ligation and cuaac on cells or on purified proteins takes 40 min-3 h.
IntroDuctIon
PRIME is a versatile tool for site-specific tagging of proteins with chemical probes that possess useful biophysical properties such as fluorescence or photo-cross-linking ability [1] [2] [3] , enabling functional studies of a given protein in vitro or in cells. The central component of the PRIME method is an engineered mutant of E. coli LplA that catalyzes the covalent tagging of the desired probe onto a specific lysine residue within a 13-aa recognition sequence called the LplA acceptor peptide (LAP), which is genetically fused to the protein of interest. LplA's high specificity for the single lysine in LAP ensures that there is no labeling of other proteins that are present in the labeling environment (such as other cellular proteins), nor is there any labeling of other sites within the LAP fusion protein. Probe targeting can be accomplished in a single step if the probe is small enough to fit into the engineered small-molecule binding pocket of LplA. The fluorescent probes coumarin 2 , Pacific Blue 4 , aminocoumarin 5 and resorufin (D.S.L. et al., unpublished results), as well as the photo-cross-linker aryl azide 6 , have been targeted in this way. Larger fluorophores and probes that cannot fit into the LplA active site-including most green and red organic fluorophores and quantum dots (QDs)-must be targeted in two steps: first, by using LplA to ligate a functional group handle to LAP, and second, by using bio-orthogonal ligation chemistry 1, 3, 7 or a protein-ligand binding interaction 8 to target the probe to the functional group handle.
As the labeling efficiency of two-step PRIME depends not only on LplA ligation kinetics but also on the kinetics of the derivatization chemistry, the best schemes use fast derivatization reactions such as the inverse-electron-demand Diels-Alder cycloaddition 3 , chelation-assisted CuAAC 1 and HaloTag-mediated labeling 8 . Among our two-step labeling schemes, PRIME with Halotag is most suited for QD targeting to cell-surface proteins because of HaloTag's superior labeling kinetics over all bio-orthogonal chemistries (QDs can only be practically supplied for cell labeling at low-nanomolar concentrations), whereas PRIME with DielsAlder is our best protocol for labeling intracellular proteins with diverse organic probes. For site-specific labeling of cell-surface proteins or purified proteins with small molecules, which is the focus of this protocol, PRIME with chelation-assisted CuAAC is preferred over PRIME with HaloTag or Diels-Alder chemistry. This is because HaloTag adds undesired steric bulk (35 kDa) to the protein of interest, which could disrupt its function, and trans-cyclooctene and tetrazine reagents for Diels-Alder are not as synthetically accessible as reagents for CuAAC.
In two-step labeling with PRIME and chelation-assisted CuAAC, a copper-chelating pAz molecule is used as the LplA substrate (Fig. 1a) . pAz ligation onto LAP-tagged cell-surface proteins can be accomplished in two distinct ways (Fig. 1b) . The first option is to add purified LplA mutant ( W37V LplA) to the cell culture medium along with the pAz probe and ATP 1 . This protocol tags the cell-surface pool of a LAP fusion protein selectively, not labeling intracellular subpopulations in the endoplasmic reticulum (ER) or Golgi. The second option is to co-express with the LAP fusion construct an LplA mutant targeted to the cell's ER. For this option, we use a quadruple mutant of LplA shown to have higher activity in the secretory pathway than the simple W37V LplA mutant. This construct is called W37A,T57I,F147L,H267R LplA or AILR LplA (ref. 9) .
Once pAz is ligated to LAP, it is chemoselectively derivatized with alkyne-probe conjugates via chelation-assisted CuAAC. This variant of CuAAC is faster (as a result of increased local copper concentration induced by the picolyl moiety) and is more cell compatible (because of the lower concentration requirement for toxic copper) than conventional CuAAC using alkyl azides 1 .
Because pAz is charged, it does not efficiently cross the plasma membrane of living cells. Consequently, for the PRIME labeling option using ER-expressed AILR LplA (Fig. 1b) , it is necessary to protect pAz as an acetoxymethyl (AM) ester (Fig. 2) so that it can access LplA in the ER. Once inside the cell, the AM ester is cleaved by endogenous cellular esterases, releasing the parent pAz. Before unmasking, pAz-acetoxymethyl ester (pAz-AM) itself does not act as an LplA substrate, because a free carboxylate is required for conjugation of the probe to LAP.
Site-specific protein labeling using PRIME and chelation-assisted click chemistry including neurexin, neuroligin and kinesin. The labeling is highly specific in all eukaryotic cell types we have tested, including yeast, human cell lines and rat neurons. Versatile chemical probe targeting to cell-surface proteins can be useful for diverse applications, such as single-molecule tracking of receptor motion 11 , superresolution imaging of cell-surface adhesion proteins and receptors 12, 13 and imaging assays that probe the fate and properties of the surface subpopulation of proteins 14 (as opposed to the total or intracellular protein pool). PRIME-CuAAC can also be adapted not only for imaging specific cellular proteins but also for monitoring proteinprotein interactions. In a separate study, we have used interactiondependent PRIME-CuAAC tagging to visualize trans-cellular neurexin-neuroligin interactions in cultured human embryonic kidney (HEK) 293T cells and rat neurons 9 .
Apart from its pairing with PRIME, chelation-assisted CuAAC is by itself useful for a variety of detection assays. For example, we have shown that it can be used to detect proteins and RNA metabolically labeled in live cells with azide analogs 1 .
Comparison with other protein-labeling methods Two-step PRIME-CuAAC labeling offers several advantages over existing site-specific protein-labeling methods. First, the total label size is small (13 aa for LAP plus the fluorophore of interest joined via a stable triazole linker as in Fig. 1a) , ensuring minimal interference with the protein of interest, unlike the much larger GFP 15 , SNAP 16 and HaloTag 17 labels (which range between 20 kDa and 35 kDa). Second, the label is monomeric and will not induce artificial cross-linking like wild-type streptavidin 18 and antibodies 19 . Third, both labeling steps are kinetically efficient, and therefore these steps can be performed quickly and with low concentrations of precious reagents without sacrificing yield. This contrasts with strain-promoted azide-alkyne cycloaddition-based labeling 7 and the aliphatic aldehyde tag 20, 21 , for example, whose much slower second-order rate constants result in lower labeling yields even when much higher probe concentrations are used. Fourth, labeling is highly specific, not only because of the inherent specificity of LplA-mediated ligation and CuAAC but also because the reaction partners (LAP, pAz and alkyne) are biologically inert until reaction catalysts (LplA, then copper) are supplied. This contrasts with components in many protein-labeling methods (e.g., FlAsH 22 ) and bioorthogonal ligation chemistries 3, 23 that have side reactions with endogenous biomolecules. Finally, even though PRIME-CuAAC labeling requires tailored small-molecule reagents, the reagents are straightforward to synthesize or commercially available and are stable during long-term storage.
Limitations
At 13 aa, the LAP tag can still interfere with the function or trafficking of proteins to which it is fused. If possible, one should perform control experiments to ensure proper functioning of the tagged recombinant protein. For example, we confirmed that LAP-tagged postsynaptic adhesion protein neuroligin-1 traffics correctly to the postsynapse, via colocalization analysis with a postsynaptic protein marker fused to a fluorescent protein 1, 9 , and that its binding to its adhesion partner neurexin is not impaired by the introduction of a labeling tag.
One should also ensure that overexpression of the tagged protein does not alter its function. If needed, expression levels of the protein can be tuned by using tunable promoters or promoters of different strengths, or by generating stable cell lines.
Even at a copper concentration of 10-40 µM, CuAAC can still be somewhat toxic to cells and damaging to proteins. We have included measures to ensure maximal cell viability when performing CuAAC, including the use of the best Cu I -stabilizing ligands available, immediate sequestration of copper ions after labeling (via use of the cell-compatible copper chelator bathocuproin sulfonate) and the addition of the radical scavenger 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPOL) to quench reactive oxygen species. By using the optimized protocol presented here, we show that chelation-assisted CuAAC is as nontoxic as copper-free strain-promoted azide-alkyne cycloaddition and can be performed on delicate cultured rat neurons 1 . As CuAAC toxicity directly correlates with the amount of copper used and the labeling duration, one should finely tune these two parameters to obtain a balance between maximal signal and minimal disruption of cellular and protein function.
In its current form, the two-step PRIME-CuAAC process is not applicable to the labeling of intracellular proteins. Although pAz ligation can occur effectively inside the cytosol, it is currently not possible to perform CuAAC inside living cells for many reasons. First, Cu I/II would need to be delivered across the cell membrane. Second, once inside, glutathione in the cytosol would likely reduce any Cu II species to the CuAACcompetent Cu I species, but a major problem would be the sequestration of Cu I by the same thiol. Third, cell-protective Cu I ligands such as THPTA and bis[(tertbutyltriazoyl)methyl]-[(2-carboxymethyltriazoyl)methyl]-amine (BTTAA) must also be delivered across the cell membrane. Designing LAP-tagged cell-surface proteins LAP sequence. The most kinetically efficient LAP, called LAP2 (GFEIDKVWYDLDA) 24 , generally works best and should be tested first as a fusion tag to the protein of choice. An alternative LAP sequence, called LAP4.2 (GFEIDKVWHDFPA) 24 , has also performed well in our hands, especially when fused to cell-surface proteins. In the case that expression, surface trafficking or labeling of a LAP2-tagged protein is problematic, one should test LAP4.2 as a possible remedy, along with other strategies such as changing the LAP fusion site or inserting a linker to increase flexibility around the LAP sequence. To increase labeling signal, tandem LAPs (such as 2× or 3× LAP) can also be used, although one caveat is that there might be a decrease in surface trafficking of the fusion protein as a result of the larger, more disordered tag.
LAP fusion site. LplA can catalyze probe ligation onto LAP at the N terminus, C terminus or in an internal loop of a protein.
For tagging of cell-surface proteins as described in this protocol, the LAP sequence must be on the extracellular or luminal face of the protein. If needed, include a few glycines or serines on either side of the LAP sequence to separate LAP from the folded protein domain and to make LAP more sterically accessible to LplA.
Probe synthesis.
A synthetic route to access the pAz substrate for LplA (structure 5) is shown in Figure 2 . To access other pAz derivatives such as pAz-fluorophore conjugates, one can use the succinimidyl ester of 6-azidomethylnicotinic acid 4 to react with an amine of choice. Many alkyne-fluorophore conjugates can be purchased (for example, from Life Technologies or Sigma-Aldrich) or synthesized in a single step via amide coupling between a commercially available fluorophore-succinimidyl ester and an aminoalkyne such as propargylamine 1 .
Design of labeling experiments. In the initial protein-labeling tests (whether at the cell surface or in vitro), it is best to include negative controls (omit LplA, omit pAz, omit copper or introduce a Lys→Ala point mutation in LAP; Fig. 3a ) in order to ensure that the labeling signal is specific and results from the activity of LplA and the chemistry of CuAAC. When designing the protein construct, it is very helpful to insert a short epitope tag (for example, hemagglutinin (HA), FLAG, c-Myc or V5), in addition to the LAP tag, so that one can verify expression of the fusion protein by immunofluorescence staining or western blotting, independent of PRIME-CuAAC labeling.
To selectively label the cell-surface pool of a protein with PRIME-CuAAC labeling, at least one of the labeling steps must be performed on live cells with membrane-impermeant reagents, so that the intracellular protein pool will not be labeled. If PRIME ligation with pAz is performed on live cells with exogenously supplied W37V LplA, the CuAAC derivatization step is flexible: it can be performed on living cells to enable real-time tracking of surface proteins, or it can be performed after cells are fixed and permeabilized. For the purpose of detecting protein localization, the fixed-cell CuAAC protocol should be considered, as it provides more sensitive detection than live-cell CuAAC (because moreforcing CuAAC reaction conditions, such as higher copper concentrations, can be used), and any residual toxicity from CuAAC becomes irrelevant. If PRIME ligation of pAz is performed with AILR LplA-ER, intracellular pools of the protein will also be tagged Figure 3 | Cell-surface protein labeling via PRIME and chelation-assisted CuAAC. (a) Demonstration of labeling specificity. Rat hippocampal neurons (at 14 d in vitro) expressing LAP-neuroligin-1 (LAP on the extracellular N terminus) and Homer1b-GFP were labeled live with 10 µM W37V LplA, 200 µM pAz and 1 mM ATP for 20 min at 37 °C. After two rounds of washing, cells were fixed using formaldehyde and blocked with 0.5% (wt/vol) casein. CuAAC was performed using 1 mM CuSO 4 , 100 µM TBTA, 2.5 mM sodium ascorbate and 5 µM AF647-alkyne for 1 h at room temperature. Negative controls are shown with pAz omitted during the PRIME step, CuSO 4 omitted during CuAAC or AP-tagged neuroligin-1 replacing LAPneuroligin-1 (AP = acceptor peptide for biotin ligase 29 rather than LplA). (b) Comparison of PRIME ligation of pAz at the cell surface versus within the ER. HEK cells expressing LAP-neurexin-1β (LAP on the extracellular N terminus), AILR LplA-ER and histone 2B-YFP (a transfection marker) were labeled with exogenous W37V LplA as in a (left), or with 100 µM pAz-AM for 1 h at 37 °C (right). Thereafter, CuAAC was performed on the live HEK cells using 50 µM CuSO 4 , 300 µM BTTAA, 2.5 mM sodium ascorbate and 20 µM AF647-alkyne for 5 min at room temperature. Quantification shows that the AF647 signal is ~4.6-fold higher in the case of exogenous labeling. DIC, differential interference contrast. Scale bars, 10 µm. Figure 3a . Then, cells were either labeled live by CuAAC using 50 µM CuSO 4 , 250 µM BTTAA, 2.5 mM sodium ascorbate, 100 µM TEMPOL and 20 µM AF647-alkyne for 5 min, or they were fixed. For fixed cells, CuAAC was performed as described in Figure 3a , except that the AF647-alkyne concentration was varied (1, 5 or 20 µM). All AF647 images are shown with the same intensity thresholds. For fixed-cell CuAAC, higher labeling signals were obtained, as well as higher background due to nonspecific binding of AF647-alkyne. DIC, differential interference contrast. Scale bars, 10 µm.
with pAz in addition to the surface pool. It is thus necessary to use live-cell CuAAC (copper ions are not membrane-permeant) after ER-pAz ligation if one wants to detect only the surface pool of the protein.
For labeling of the surface pool of a protein, we generally recommend using purified W37V LplA over AILR LplA-ER as the former is approximately four-to fivefold more sensitive than the latter (Fig. 3b) . AILR LplA-ER is technically simpler and might be advantageous in certain biological applications, such as labeling and imaging in tissue slices, in which protein delivery may be a concern. Performing pAz ligation in the ER also eliminates the need to add ATP during labeling, which is a preferred practice for neuron cultures as ATP can activate purinergic receptors in neurons and cause excitotoxicity 25 .
When performing live-cell CuAAC on hardy cell lines (for example, HEK 293T, HeLa and COS-7 cells), one can omit the cell-protective reagents TEMPOL and bathocuproin sulfonate without affecting labeling efficiency. One should not omit these reagents when working with more delicate cells such as neurons.
The choice of fluorophore-alkyne and its labeling concentration matters for both live-cell and fixed-cell CuAAC. For live-cell CuAAC, choose fluorophores that are not membrane-permeable (such as the Alexa Fluor (AF) dyes, almost all of which are polysulfonated) to avoid intracellular uptake. For fixed-cell CuAAC, it is also best to choose polysulfonated, hydrophilic fluorophores in order to minimize nonspecific sticking to fixed cells. A higher fluorophore-alkyne concentration results not only in faster CuAAC labeling but also in greater nonspecific sticking. Ideally, one should perform a titration of dye concentrations to identify conditions that give a maximal signal-to-noise ratio. An example of cell-surface protein labeling with both the live-cell and fixed-cell CuAAC protocols, at different fluorophore-alkyne concentrations, is shown in Figure 4 . In this example, 5 µM AF647-alkyne for fixed-cell CuAAC provides the highest signal-to-noise ratio.
For labeling purified proteins ( Fig. 5) , we describe the expression and purification of two LplA variants: hexahistidine (His 6 )-tagged W37V LplA (His 6 -W37V LplA) and tagless W37V LplA. The choice of which enzyme to use depends on how one wishes to purify proteins after PRIME labeling. For example, it is helpful to use tagless LplA to label a His 6 -tagged protein so that the latter can be easily separated from LplA after labeling. In contrast, His 6 -tagged LplA can be used to label a protein with an orthogonal purification tag (such as FLAG or GST). 
MaterIals
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Box 1 | W37V LplA expression and purification • tIMInG 4-5 d
If you are planning to perform exogenous cellular labeling with pAz (Step 2A of the PROCEDURE) or labeling of a purified protein, then you need to express and purify W37V LplA. If pAz ligation will be performed with ER-targeted AILR LplA (Step 2B of the PROCEDURE), this procedure is not required. Modules A and B describe the expression and purification of His 6 -W37V LplA. These same steps could also be performed to prepare His 6 -ENLYFQG-W37V LplA. Module C describes how to remove the His-tag from His 6 -ENLYFQG-W37V LplA and purify the resulting tagless W37V LplA. TEV protease-mediated cleavage of the ENLYFQG sequence removes His 6 -ENLYFQ (cleavage occurs between glutamine and glycine) from W37V LplA. Thereafter, the reaction mixture is run through nickel-NTA resin, which selectively retains His 6 -ENLYFQ peptide and His 6 -AcTEV protease, and allows tagless W37V LplA to flow through.
(a) expression of His 6 -W37V lpla in E. coli (i) Transform chemically competent BL21 (DE3) pLysS E. coli with pYFJ16-W37V LplA, and plate it on an LB-ampicillin agar plate.
Incubate the plate at 37 °C overnight.
(ii) Pick one colony from the plate and inoculate it into 5 ml of LB-ampicillin (LB with 100 µg ml − 1 ampicillin). Shake the flask at 220 r.p.m. at 37 °C overnight. (iii) To make an expression culture, dilute the 5-ml overnight culture into 500 ml of LB-ampicillin in a 2-liter culture flask. Shake the culture flask at 37 °C until the A 600 value reaches 0.5.  crItIcal step For maximal LplA protein yield, it is better to induce expression when the A 600 value is below 0.7. Once the A 600 value reaches 0.1, the cell density should double every 20 min. (c) preparation of tagless W37V lpla from His 6 -enlYFQG-W37V lpla (i) Express and purify His 6 -ENLYFQG-W37V LplA as described in steps A and B above.
(ii) After nickel-NTA purification, dialyze the protein aliquots in LplA dialysis buffer twice, each time for >6 h, against at least 1,000-fold ice-cold buffer at 4 °C. (iii) Further dialyze LplA twice in TEV protease cleavage buffer, each time for >6 h, against at least 1,000-fold ice-cold buffer at 4 °C. After dialysis, measure the LplA concentration to make sure that it does not exceed 5 mg ml -1 ; make dilutions if necessary. We typically work with a 2-3 mg ml -1 solution during the protease cleavage step.  crItIcal step Do not directly dialyze LplA into TEV protease cleavage buffer, which does not contain glycerol and can cause LplA to precipitate. EQUIPMENT SETUP Glassware and stir bars Glassware and stir bars used for tosylation, succinimidyl ester formation, AM ester formation and amide coupling reactions should be dried before use in an oven or by flame drying.  crItIcal These reactions are conducted using anhydrous solvents under inert atmosphere. The presence of moisture in the reaction vessels from improper drying can cause unwanted hydrolysis of the reagents or desired products. Glass coverslips for cell plating Cut no. 1 (22 × 22 mm) or no. 1.5 coverslips by hand into squares of 7 × 7 mm using a diamond glass cutter. The cut coverslips are sterilized by irradiation under a UV lamp in the cell culture hood for at least 1 h. Mammalian cells are then grown on these cut coverslips placed in a 48-well plate.  crItIcal We often perform cell-labeling experiments in a 48-well plate format to conserve precious labeling reagents.
In each well of a 48-well plate, only ~150 µl of the labeling solution is needed. For imaging, we transfer the coverslip to an imaging dish with a no. 1 glass bottom. 
Box 1 | (continued)
(
1|
Depending on whether you are planning to label the cell-surface protein exogenously (using exogenous W37V LplA) or endogenously (using AILR LplA-ER), you should prepare either pAz or pAz-AM. To label purified proteins, use pAz. To prepare pAz, perform modules A-D (Steps 1A-1D); to prepare pAz-AM, perform modules A-E (Steps 1A-1E).
(a) synthesis of methyl 6-(hydroxymethyl)nicotinate 2 • tIMInG 6 h (i) Weigh 10.0 g of dimethyl 2,5-pyridine dicarboxylate (51.2 mmol) and 22.8 g of anhydrous CaCl 2 (205.4 mmol), and then transfer both to a 1-liter round-bottom flask equipped with an ice bath. Transfer 100 ml of anhydrous THF and 200 ml of anhydrous methanol to the flask and stir the slurry mixture. Allow the mixture to cool to 0 °C for 5-10 min. (ii) Weigh 3.9 g of NaBH 4 (103.1 mmol), and then transfer it in portions to the reaction flask. Stir the reaction at 0 °C for ~2 h. (iii) Quench excess NaBH 4 by adding 100 ml of ice-cold water to the reaction mixture. (iv) (Optional) Concentrate the reaction mixture using rotary evaporation until the total volume is reduced to ~150 ml.
This makes the subsequent extraction step easier to handle. (v) Extract the reaction mixture four times with chloroform (70 ml for each extraction). Combined organic extract is washed twice with water, dried with sodium sulfate and concentrated using rotary evaporation to obtain methyl 6-(hydroxymethyl)nicotinate 2 as a white solid (4.5 g, 52% yield). R f = 0.27 (1:1 hexanes/ethyl acetate).  crItIcal step The aqueous wash step is crucial, as it removes a polar by-product (caused by over-reduction of two esters instead of one) without the need for a subsequent chromatographic purification step.  pause poInt Methyl 6-(hydroxymethyl)nicotinate can be stored at −20 °C for >1 year.  crItIcal step Take care not to prolong the LiOH hydrolysis step, as the azido group can be labile under aqueous basic conditions. (iii) Add ~700 µl of acetic acid to the reaction mixture and concentrate the crude mixture using rotary evaporation. (iv) Purify the resulting residue by flash chromatography on silica, using isocratic ethyl acetate + 1% (vol/vol) acetic acid, to obtain 6-azidomethylnicotinic acid 4 as a yellow solid (1.12 g, 92% yield). R f = 0.35 (ethyl acetate + 1% acetic acid).  pause poInt Store 6-azidomethylnicotinic acid at −20 °C for >1 year. paz ligation onto cell-surface proteins with lpla 2| pAz ligation can be performed exogenously with purified W37V LplA (option A) or endogenously with AILR LplA-ER (option B). Exogenous pAz ligation with W37V LplA is our recommended protocol for most cell-surface protein-labeling experiments as it is more sensitive than pAz ligation in the ER. Users should only consider using AILR LplA-ER if it is known that: the 39 kDa LplA might have problems accessing the labeling site on the protein of interest at the cell surface, whereas such hindrance is not present if the labeling is performed within the ER, or the reagents required for exogenous labeling such as ATP are toxic to the cell type of interest. Relating to the toxicity concern, note that pAz-AM needed for ER labeling is not water soluble and has to be supplied as a DMSO stock, which increases the toxicity of the ER labeling procedure. pAz needed for exogenous LplA labeling, in contrast, is water soluble. Note that this step is not required for labeling of purified proteins; users wanting to do this should proceed to Box 2. (a) paz ligation of cell-surface proteins using exogenous W37V lpla • tIMInG 2 d (i,ii); 15 min-1 h (iii,iv) (i) Plate the cells onto 7-mm × 7-mm coverslips in a 48-well plate. For HEK cells, we coat coverslips with human fibronectin (50 µg ml -1 ) according to the manufacturer's instructions, and we generally plate ~8,000 cells in 250 µl of medium per well. This cell density should result in cells that are 80% confluent ~24 h after plating, which is optimal for Lipofectamine transfection.  crItIcal step Do not use any buffer that contains high Ca 2 + (such as Ca 2 + -containing DPBS or Tyrode's buffer) during labeling, as Ca 2 + inhibits LplA. If serum-containing medium is used as a labeling buffer, check that the lipoic acid content in the serum is not too high (not more than 5 µM). Lipoic acid is a natural, more efficient substrate for LplA than pAz and will reduce the labeling yield of pAz. (iv) Wash the cells at least twice with cell growth medium to remove labeling agents before proceeding to the CuAAC derivatization step.  crItIcal step For cultured neurons, ensure that the neurons are not exposed to air for longer than 2-3 s during reagent addition or wash steps. You can use two pipettes to simultaneously add and withdraw solution from the wells. 31 , which includes a detailed protocol on how to perform CuAAC on biomolecules, including proteins, in vitro. Pay attention to many of their recommendations with respect to how to perform optimal CuAAC, such as which buffers are compatible with CuAAC. We have used 200 µM CuSO 4 , 1 mM BTTAA (THPTA can likewise be used), 20 µM AF647-alkyne, 2.5 mM sodium ascorbate and 100 µM TEMPOL to label ~10 µM LAP-kinesin for 30 min at room temperature; we observed that labeling signal was already saturated after 30 min of CuAAC.
estimation of in vitro protein labeling yield 5. After excess fluorophore is removed from the protein sample via gel filtration, dialysis or centrifugal washing, one can estimate the overall labeling yield on the protein by measuring the dye-to-protein molar ratio. Measure the A 280 value and the maximal absorbance at a particular wavelength for each fluorophore (for example, A 650 for AF647) to determine the molar concentration of the protein and the fluorophore in a given sample, respectively. To calculate molar concentrations, find out the extinction coefficients (ε) of the protein and the fluorophore. If the value of ε of a protein is not known in the literature or cannot be determined experimentally, one can roughly estimate ε from the protein's primary sequence using computational means (for example, ProtParam tool from ExPASy, which estimates ε on the basis of the cysteine, tryptophan and tyrosine present in a given protein). As fluorophores also absorb at 280 nm, one must apply correction factors for the portion of the A 280 value that is contributed by the fluorophore. Information about fluorophores' extinction coefficients and A 280 correction factors, as well as more details on dye-to-protein ratio calculation, can be obtained from the websites of common fluorophore manufacturers and vendors.
 crItIcal step Do not use THPTA or BTTAA for fixed-cell CuAAC labeling. 
